PURPOSE: The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in 2009 and recommended for routine administration in 2011. The purpose of this study was to uncover predictable commonalities amongst parents who chose to vaccinate their 11-17 year old sons against HPV. METHODS: We compiled data from a U.S. national sample of 779 parents with sons 11-17 years old using a web-based survey to gather information about behavioral and sociodemographic factors which predicted receipt of 1 or more HPV vaccine doses based on parental report. Predictors were first modeled individually for univariable associations. Significant predictors (p<0.10) were combined in a multivariable model. RESULTS: In the adjusted model, ind...
OBJECTIVE: The quadrivalent and 9-valent human papillomavirus (HPV) vaccines are licensed for admini...
poster abstractBackground: Human papillomavirus (HPV) is an very common infection that is a primary ...
We examined parents’ and adolescents’ preferences regarding potential strategies to increase HPV vac...
<div><p>Purpose</p><p>The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in...
PURPOSE: The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in 2009 and rec...
Purpose: The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in 2009 and rec...
In 2009, the United States approved quadrivalent HPV vaccine for males 9–26 years old, but data on v...
US guidelines provided a permissive recommendation forHPV vaccine for males in 2009, with an updated...
In 2009, the United States approved quadrivalent HPV vaccine for males 9–26 years old, but data on v...
US guidelines provided a permissive recommendation forHPV vaccine for males in 2009, with an updated...
We examined mothers' willingness to get their adolescent sons HPV vaccine. In December 2009, 2 month...
Background: Human papillomavirus (HPV) vaccine has been recommended for males in the United States s...
We examined parents’ and adolescents’ preferences regarding potential strategies to increase HPV vac...
A quadrivalent vaccine against human papillomavirus (HPV; i.e., HPV4) was approved for use in males ...
A quadrivalent vaccine against human papillomavirus (HPV; i.e., HPV4) was approved for use in males ...
OBJECTIVE: The quadrivalent and 9-valent human papillomavirus (HPV) vaccines are licensed for admini...
poster abstractBackground: Human papillomavirus (HPV) is an very common infection that is a primary ...
We examined parents’ and adolescents’ preferences regarding potential strategies to increase HPV vac...
<div><p>Purpose</p><p>The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in...
PURPOSE: The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in 2009 and rec...
Purpose: The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in 2009 and rec...
In 2009, the United States approved quadrivalent HPV vaccine for males 9–26 years old, but data on v...
US guidelines provided a permissive recommendation forHPV vaccine for males in 2009, with an updated...
In 2009, the United States approved quadrivalent HPV vaccine for males 9–26 years old, but data on v...
US guidelines provided a permissive recommendation forHPV vaccine for males in 2009, with an updated...
We examined mothers' willingness to get their adolescent sons HPV vaccine. In December 2009, 2 month...
Background: Human papillomavirus (HPV) vaccine has been recommended for males in the United States s...
We examined parents’ and adolescents’ preferences regarding potential strategies to increase HPV vac...
A quadrivalent vaccine against human papillomavirus (HPV; i.e., HPV4) was approved for use in males ...
A quadrivalent vaccine against human papillomavirus (HPV; i.e., HPV4) was approved for use in males ...
OBJECTIVE: The quadrivalent and 9-valent human papillomavirus (HPV) vaccines are licensed for admini...
poster abstractBackground: Human papillomavirus (HPV) is an very common infection that is a primary ...
We examined parents’ and adolescents’ preferences regarding potential strategies to increase HPV vac...